What Questions a Managing Partner Should Be Asking Their Marketing Leader Every Quarter

The quarterly marketing review is one of the most important — and most poorly structured — meetings in most PI firms. Managing partners walk in looking for reassurance. Marketing leaders walk in hoping not to get pressed on numbers they cannot defend. Both leave without the clarity either side actually needs.

The fix is not better slides. It is better questions. Specifically, questions that connect marketing activity to financial outcomes — and that a marketing leader with real data should be able to answer without hesitation.

These are the questions every managing partner should be asking, and what complete answers look like.

Question 1: What Is Our Cost Per Signed Case by Vendor — and How Has It Trended?

This is the single most important financial question in a marketing review. Not cost per lead. Not conversion rate. Cost per signed case — by source, not blended.

A complete answer includes: cost per case for each active vendor this quarter, the same number for the prior quarter, and a directional trend. If Vendor A was at $3,800 last quarter and is now at $5,200, you want to know before the invoice is paid, not after.

If your marketing leader cannot provide this number by vendor — if the answer is a blended average or a reference to vendor-provided reports — that is the first structural gap to close.

Question 2: Which Vendors Are Above Our Break-Even Cost Per Case?

Break-even cost per case — the maximum acquisition cost at which cases remain profitable — should be a standing benchmark in your firm's financial model. Every vendor should be evaluated against it.

A complete answer identifies which vendors are currently operating above break-even, by how much, and what the proposed remediation is. “Vendor D is at $7,400 cost per case against our $5,200 break-even. We've issued a 60-day improvement plan with a threshold of $5,500. If they do not hit it, we exit.”

If vendors above break-even are being retained without a documented remediation plan, capital is being consumed without a financial rationale.

Question 3: What Is the Expected Revenue Value of This Quarter's Signed Cases?

Signed case count is an activity metric. Expected case revenue is a financial metric. The distinction matters because not all cases are worth the same amount — and a quarter with more cases at lower average value may be less financially productive than a prior quarter with fewer cases at higher value.

A complete answer: “We signed 127 cases this quarter. Based on case type distribution and our historical average settlement by type, the expected contingency fee revenue is $892,000. That compares to $1,040,000 last quarter on 118 cases — we signed more cases but the case mix shifted toward lower-severity motor vehicle matters.”

That answer tells you something important about lead source quality that the raw case count obscures.

Question 4: What Did We Learn From Our Worst-Performing Vendor This Quarter?

Every quarter has a worst performer. The question is not whether one exists — it is whether you have the data to identify and address it quickly.

This question also tests whether your marketing leader is in a posture of accountability or defensiveness. A confident answer with data sounds like: “Vendor C dropped from 28% conversion to 19% this quarter. We believe the issue is geographic mix — they shifted toward counties where our intake team has lower close rates. We have a meeting scheduled to renegotiate territory terms.”

A defensive answer sounds like: “Vendor C has been challenging. The leads just haven't been as good.” That answer signals a lack of attribution data, not a lack of effort.

Question 5: Are We Ahead or Behind Our Signed Case Target for the Quarter?

This should be a number, not a narrative. Are we on pace? By how much? If we are behind, what is the specific plan to close the gap?

A complete answer: “We targeted 135 signed cases this quarter. We are at 127 with 18 business days remaining. At our current daily pace of 2.1 cases per day, we will close at approximately 138. We are slightly ahead.”

If your firm does not have a signed case target — and most do not — this question first requires establishing one. Revenue goals require upstream operational targets. If you want $1.2M in monthly fee revenue and your average case produces $8,500 in fees, you need 141 signed cases per month. That is the target. Without it, there is no benchmark to evaluate performance against.

Question 6: What Would You Do With 20% More Budget — and What Return Would We Expect?

This is the test of whether marketing is being managed as an investment or an expense. A marketing leader with a returns model can answer this question immediately and specifically: “We would allocate $30,000 to Vendor A, which is generating cases at $2,900 cost each and 94% expected ROI. At that cost per case, an additional $30,000 should produce approximately 10 additional signed cases worth roughly $87,000 in expected contingency fee revenue. Payback period: 12 to 18 months given the settlement lag.”

A marketing leader without that model will say: “We would test some new channels and see what performs.” That is not an investment rationale. It is a guess.

Question 7: What Is Our Marketing Spend as a Percentage of Expected Case Revenue?

This is your marketing margin — the financial efficiency ratio that tells you how much revenue you expect per dollar of marketing and acquisition cost. For mid-size PI firms, a healthy target range is 15–25% of expected contingency fee revenue allocated to marketing and intake combined.

A complete answer compares this quarter's ratio to prior quarters and to your target. If marketing spend is 28% of expected revenue and trending upward, that is a margin compression signal that warrants specific action — not just acknowledgment.

Question 8: What Are We Measuring This Quarter That We Weren't Last Year?

This question evaluates the maturity trajectory of your marketing measurement capability. Firms that are improving their financial intelligence over time are adding measurement layers: case type by source, rejection rate by source, expected settlement distribution by vendor. Firms that are static have the same visibility they had 12 months ago.

A stagnant measurement environment is a risk indicator, not just a capability gap. Over 80% of PI firms are still tracking marketing ROI manually in spreadsheets. The firms that move beyond that baseline earliest compound the advantage annually.

What to Do If Your Marketing Leader Cannot Answer These Questions

In many cases, the gap is not the marketing leader's knowledge — it is the data infrastructure available to them. A skilled marketing director without source-level attribution data cannot calculate cost per case by vendor, expected revenue per source, or marketing margin. The problem is structural, not personal.

The starting point is ensuring that every lead entering your system is tagged with its originating source, and that signed cases are linked back to those leads. Without that foundation, neither the marketing leader nor the managing partner can have the financial conversation that firm growth requires.

RevenueScale's financial reporting framework gives managing partners complete answers to every quarterly review question — built for PI firms managing $100K to $750K in monthly spend.